DR1 and Parkinson disease: showed in MPTP-induced PD mice of different genotypes that dopamine receptor 2 (DR2) or CD4-specific DR2 knock-out, instead of DR1 knock-out, could exacerbate phenotypical, pathological and inflammatory changes related to PD (220).